News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
498,021 Results
Type
Article (9960)
Company Profile (158)
Press Release (487901)
Multimedia
Podcasts (18)
Webinars (7)
Section
Business (171272)
Career Advice (368)
Deals (26343)
Drug Delivery (17)
Drug Development (54226)
Employer Resources (22)
FDA (9932)
Job Trends (8949)
News (244066)
Policy (18365)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (593)
Accelerated approval (24)
ADA (21)
Adcomms (1)
Allergies (101)
Alliances (34413)
ALS (110)
Alzheimer's disease (1017)
Antibody-drug conjugate (ADC) (310)
Approvals (10551)
Artificial intelligence (362)
ASCO (166)
Autoimmune disease (220)
Automation (32)
Bankruptcy (271)
Best Places to Work (7140)
BIO (41)
Biologics (2)
BIOSECURE Act (3)
Biosimilars (131)
BioSpace Insights (29)
Biotechnology (99)
Bladder cancer (142)
Brain cancer (34)
Breast cancer (526)
Cancer (3858)
Cardiovascular disease (231)
Career advice (296)
Career pathing (2)
CAR-T (191)
CDC (2)
CDMO (14)
Celiac Disease (1)
Cell therapy (528)
Cervical cancer (38)
Clinical research (48916)
Collaboration (1381)
Commercialization (3)
Company closure (4)
Compensation (1513)
Complete response letters (35)
COVID-19 (894)
CRISPR (71)
C-suite (847)
Cystic fibrosis (90)
Data (5891)
Denatured (10)
Depression (110)
Dermatology (65)
Diabetes (360)
Diagnostics (4339)
Digital health (39)
Diversity (2)
Diversity, equity & inclusion (4)
Drug discovery (188)
Drug pricing (16)
Drug shortages (2)
Duchenne muscular dystrophy (189)
Earnings (74386)
Editorial (6)
Employer branding (3)
Employer resources (20)
Events (89553)
Executive appointments (761)
FDA (12646)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (1065)
Gene editing (144)
Generative AI (12)
Gene therapy (368)
GLP-1 (349)
Government (1069)
Grass and pollen (2)
Guidances (285)
Healthcare (9579)
Hematology (95)
HIV (55)
Huntington's disease (24)
IgA nephropathy (67)
Immunology and inflammation (135)
Immuno-oncology (73)
Indications (159)
Infectious disease (1099)
Inflammatory bowel disease (135)
Inflation Reduction Act (8)
Influenza (89)
Intellectual property (267)
Interviews (47)
IPO (12590)
IRA (7)
Job creations (2139)
Job search strategy (281)
JPM (7)
Kidney cancer (20)
Labor market (12)
Layoffs (107)
Leadership (3)
Legal (5293)
Licensing (13)
Liver cancer (49)
Longevity (21)
Lung cancer (534)
Lymphoma (262)
Machine learning (30)
Management (7)
Manufacturing (585)
Marketing (8)
MASH (122)
Medical device (8755)
Medtech (8904)
Mergers & acquisitions (14813)
Metabolic disorders (759)
mRNA (73)
Multiple sclerosis (108)
NASH (4)
Neurodegenerative disease (245)
Neuropsychiatric disorders (53)
Neuroscience (1947)
Neurotech (1)
NextGen: Class of 2026 (3342)
Non-profit (962)
Now hiring (16)
Obesity (252)
Opinion (30)
Ovarian cancer (163)
Pain (179)
Pancreatic cancer (218)
Parkinson's disease (212)
Partnered (15)
Patents (499)
Patient recruitment (532)
Peanut (32)
People (42934)
Pharmaceutical (31)
Pharmacy benefit managers (9)
Phase 1 (15933)
Phase 2 (21909)
Phase 3 (14783)
Pipeline (7701)
Policy (33)
Postmarket research (1581)
Preclinical (6739)
Press Release (34)
Prostate cancer (194)
Psychedelics (12)
Radiopharmaceuticals (202)
Rare diseases (629)
Real estate (3257)
Recruiting (10)
Regulatory (15273)
Reports (26)
Research institute (686)
Resumes & cover letters (53)
Rett syndrome (42)
RNA editing (9)
RSV (51)
Schizophrenia (111)
Series A (195)
Series B (140)
Service/supplier (5)
Sickle cell disease (65)
Special edition (3)
Spinal muscular atrophy (90)
Sponsored (6)
Startups (2289)
Stomach cancer (5)
Supply chain (52)
Tariffs (2)
The Weekly (8)
Vaccines (374)
Venture capital (39)
Weight loss (95)
Women's health (87)
Worklife (1)
Date
Last 7 days (442)
Last 30 days (1455)
Last 365 days (19703)
2026 (13474)
2025 (20002)
2024 (23641)
2023 (27240)
2022 (35534)
2021 (38231)
2020 (34501)
2019 (24029)
2018 (18153)
2017 (19377)
2016 (18545)
2015 (24836)
2014 (22075)
2013 (18600)
2012 (20697)
2011 (20860)
2010 (20701)
Location
Africa (251)
Alabama (77)
Alaska (2)
Arizona (311)
Arkansas (11)
Asia (19082)
Australia (2296)
California (12503)
Canada (3240)
China (599)
Colorado (497)
Connecticut (427)
Delaware (212)
Europe (27318)
Florida (1834)
Georgia (387)
Hawaii (4)
Idaho (47)
Illinois (733)
India (56)
Indiana (326)
Iowa (15)
Japan (422)
Kansas (111)
Kentucky (32)
Louisiana (29)
Maine (26)
Maryland (1234)
Massachusetts (8186)
Michigan (314)
Minnesota (581)
Mississippi (5)
Missouri (85)
Montana (20)
Nebraska (11)
Nevada (119)
New Hampshire (63)
New Jersey (2705)
New Mexico (12)
New York (2873)
North Carolina (1318)
North Dakota (4)
Northern California (6312)
Ohio (301)
Oklahoma (15)
Oregon (19)
Pennsylvania (2294)
Puerto Rico (21)
Rhode Island (31)
South America (424)
South Carolina (77)
South Dakota (1)
Southern California (5147)
Tennessee (128)
Texas (2020)
United States (40315)
Utah (369)
Vermont (1)
Virginia (160)
Washington D.C. (41)
Washington State (1000)
West Virginia (2)
Wisconsin (86)
Wyoming (1)
498,021 Results for "mbx biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MBX Biosciences Reports Second Quarter 2026 Financial Results and Corporate Highlights
August 6, 2026
·
12 min read
Press Releases
MBX Biosciences Announces First Patient Dosed in Pivotal Phase 3 oPTimize Trial of Once-Weekly Canvuparatide in Adults with Hypoparathyroidism
August 27, 2026
·
8 min read
Press Releases
MBX Biosciences Announces Executive Leadership Transition to Support the Company’s Next Phase of Growth
July 13, 2026
·
7 min read
Press Releases
MBX Biosciences Provides Obesity Portfolio Update Including Initial Phase 1 Data for MBX 4291 Supporting Potential for Once-Monthly Dosing
May 11, 2026
·
12 min read
Press Releases
MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City
May 26, 2026
·
1 min read
Press Releases
MBX Biosciences Reports First Quarter 2026 Financial Results and Corporate Highlights
May 7, 2026
·
11 min read
Press Releases
MBX Biosciences to Host Virtual Investor Event to Discuss Once-Weekly Canvuparatide Presentations at ENDO 2026
June 1, 2026
·
2 min read
Press Releases
MBX Biosciences Appoints Karen Basbaum as Chief Business Officer
March 10, 2026
·
5 min read
Press Releases
MBX Biosciences Announces Appointment of Mark Soued as Chief Commercial Officer and Inducement Grant Award
May 7, 2026
·
6 min read
Press Releases
MBX Biosciences to Participate in Upcoming March 2026 Investor Conferences
February 23, 2026
·
2 min read
1 of 49,803
Next
